| Project/Area Number |
06454719
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Laboratory animal science
|
|---|
| Research Institution | Cancer Institute |
|---|
Principal Investigator |
HINO Okio Cancer Institute, Department of Experimental Pathology, Chief, 実験病理部, 部長 (90127910)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KOBAYASHI Toshiyuki Cancer Institute, Department of Experimental Pathology, Associate, 実験病理部, 研究員 (40260070)
久保 宜明 財団法人癌研究會, 癌研究所・実験病理部, 研究員 (10260069)
|
|---|
| Project Period (FY) |
1994 – 1995
|
| Project Status |
Completed (Fiscal Year 1995)
|
| Budget Amount *help |
¥6,400,000 (Direct Cost: ¥6,400,000)
Fiscal Year 1995: ¥2,600,000 (Direct Cost: ¥2,600,000)
Fiscal Year 1994: ¥3,800,000 (Direct Cost: ¥3,800,000)
|
|---|
| Keywords | Hereditary cancer / Animal model / Renalcarcinogenesis / TSC2 gene / Tuberous sclerosis / Tumor suppressor gene / 遺伝性腎癌 |
|---|
| Research Abstract |
The Eker rat model of hereditary renal carcinoma, originally reported by R.Eker in 1954, is an example of Mendelian dominantly inherited predisposition to a specific cancer in an experimental animal. Finally, we identified a germline retrotransposon insertion in the rat homologue of the human tuberous sclerosis (TSC2) gene, 40 years after the discovery of the Eker rat in Oslo.
|
